4.5 Article

Osteoprotegerin in relation to insulin resistance and blood lipids in sub-Saharan African women with and without abdominal obesity

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biotechnology & Applied Microbiology

Role of osteoprotegerin in vascular disorders of the end-stage renal disease patients

Diana Moldovan et al.

BIOMARKERS (2015)

Article Endocrinology & Metabolism

Osteoprotegerin is not a determinant of metabolic syndrome in sub-Saharan Africans after age adjustment

Clarisse Noel Ayina Ayina et al.

ANNALES D ENDOCRINOLOGIE (2014)

Review Multidisciplinary Sciences

Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications

Mette Bjerre

SPRINGERPLUS (2013)

Review Endocrinology & Metabolism

How can we measure insulin sensitivity/resistance?

B. Antuna-Puente et al.

DIABETES & METABOLISM (2011)

Article Endocrinology & Metabolism

Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus

Jong Suk Park et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)

Review Cardiac & Cardiovascular Systems

Osteoprotegerin, vascular calcification and atherosclerosis

Ann Van Campenhout et al.

ATHEROSCLEROSIS (2009)

Article Cardiac & Cardiovascular Systems

Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice

Sean Morony et al.

CIRCULATION (2008)

Article Hematology

Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE(-/-) mice

Brian J. Bennett et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)